CD4 and myeloid sarcoma: Patients with MS older than 60 years exerted reduced capacity of coinhibitory immune cell signaling and prominent increase in the levels of circulating cytotoxic CD4+ T cells, which play a role in compartmentalized CNS inflammation in progressive MS.32,33